mTOR Inhibition and Clinical Transplantation: Kidney.
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/tp.0000000000001692
Abstract: T mammalian target of rapamycin (mTOR) inhibitor class of immunosuppressive drugs were introduced more than 15 years ago as a new opportunity to create selective antirejection therapy in solid organ transplantation. In particular, absence of… read more here.
Keywords: clinical transplantation; inhibition clinical; mtor inhibition; transplantation ... See more keywords
mTOR Inhibition and Clinical Transplantation: Heart.
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/tp.0000000000001921
Abstract: This brief overview discusses recent data on the use of mammalian target of rapamycin (mTOR) inhibitors in heart transplantation. Trials on de novo use have shown good efficacy of mTOR inhibitors; however, adverse events are… read more here.
Keywords: heart; clinical transplantation; inhibition clinical; mtor inhibition ... See more keywords
Comprehensive evaluation of decellularized porcine corneal after clinical transplantation
Sign Up to like & getrecommendations! Published in 2017 at "Xenotransplantation"
DOI: 10.1111/xen.12338
Abstract: Corneal disease is the second most common blinding disease in the world. The shortage of cornea donors has become the greatest challenge in curing corneal disease. Decellularized porcine corneas have the potential to be clinically… read more here.
Keywords: clinical transplantation; cornea; decellularized porcine; porcine corneal ... See more keywords